3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Burkitt Lymphoma
9
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
3
Precursor Cell Lymphoblastic Leukemia-Lymphoma
3
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma
3
Multiple Myeloma
3
Down Syndrome
3
Lymphoma, Mantle-Cell
2
Lung Neoplasms
2
Leukemia, Biphenotypic, Acute
2
Smoldering Multiple Myeloma
1
Neoplasms
1
Leukemia, Plasma Cell
1
Immunoglobulin Light-chain Amyloidosis
1
Esophageal Neoplasms
1
Dyspnea
1
Carcinoma, Non-Small-Cell Lung
1
Interventions
pembrolizumab
19
Specimen Handling
19
Biopsy
13
Magnetic Resonance Spectroscopy
12
Carboplatin
11
Paclitaxel
10
Pemetrexed
8
Nivolumab
7
Irinotecan
7
Gemcitabine
7
trastuzumab deruxtecan
6
Fulvestrant
6
Radiosurgery
5
Leucovorin
5
Fluorouracil
5
Cisplatin
5
Cetuximab
5
Bevacizumab
5
palbociclib
4
durvalumab
4
Taxes
4
Oxaliplatin
4
Letrozole
4
Docetaxel
4
ribociclib
3
olaparib
3
Trastuzumab
3
Panitumumab
3
Midazolam
3
Ipilimumab
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Neoplasm Metastasis
×
dexamethasone acetate
×
30 days
×
Clear all
No trials found.